HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patricia S Steeg Selected Research

Neuroinflammatory Diseases

10/2015Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patricia S Steeg Research Topics

Disease

63Neoplasm Metastasis (Metastasis)
02/2024 - 08/2002
61Neoplasms (Cancer)
11/2023 - 11/2002
57Breast Neoplasms (Breast Cancer)
02/2024 - 01/2002
39Brain Neoplasms (Brain Tumor)
02/2024 - 01/2007
7Triple Negative Breast Neoplasms
11/2023 - 10/2009
7Neoplasm Micrometastasis
01/2023 - 08/2008
2Fibrosis (Cirrhosis)
05/2018 - 01/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010 - 09/2007
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2023
1Thrombocytopenia 1
01/2023
1Lymphopenia (Lymphocytopenia)
01/2023
1Neutropenia
01/2023
1Gliosis
01/2021
1Glioblastoma (Glioblastoma Multiforme)
05/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Inflammation (Inflammations)
11/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
11/2023 - 08/2002
7Small Interfering RNA (siRNA)IBA
01/2019 - 08/2007
6DNA (Deoxyribonucleic Acid)IBA
12/2016 - 10/2009
6Phosphotransferases (Kinase)IBA
02/2015 - 02/2003
5Trastuzumab (Herceptin)FDA Link
02/2024 - 10/2005
5Temozolomide (Temodar)FDA LinkGeneric
01/2023 - 02/2008
5Lysophosphatidic Acid ReceptorsIBA
05/2018 - 08/2007
5Biomarkers (Surrogate Marker)IBA
12/2016 - 07/2006
5Paclitaxel (Taxol)FDA LinkGeneric
11/2013 - 04/2007
5Messenger RNA (mRNA)IBA
12/2011 - 05/2007
4CytokinesIBA
11/2019 - 12/2008
4ErbB Receptors (EGF Receptor)IBA
01/2019 - 05/2007
4Histidine KinaseIBA
02/2018 - 08/2002
4Lapatinib (GW572016)FDA Link
02/2015 - 08/2008
4Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
11/2014 - 09/2003
3Histidine (L-Histidine)FDA Link
02/2018 - 08/2002
3Hormones (Hormone)IBA
11/2014 - 05/2005
3pazopanibFDA Link
06/2013 - 01/2011
2biocytinIBA
02/2024 - 01/2023
2Phenobarbital (Luminal)FDA Link
11/2023 - 01/2021
2AntibodiesIBA
01/2021 - 11/2020
2Immunoconjugates (Immunoconjugate)IBA
11/2020 - 01/2019
2human ERBB2 proteinIBA
11/2020 - 03/2015
2Estrogen ReceptorsIBA
01/2019 - 01/2007
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 09/2007
2Dextrans (Dextran)FDA Link
01/2018 - 11/2016
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2018 - 01/2013
2Coloring Agents (Dyes)IBA
01/2018 - 11/2016
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2016 - 11/2013
2Texas redIBA
12/2016 - 11/2016
2Complementary DNA (cDNA)IBA
07/2014 - 08/2008
2Tyrosine (L-Tyrosine)FDA Link
06/2013 - 02/2003
2Tyrosine Kinase InhibitorsIBA
06/2013 - 01/2013
2IronIBA
07/2011 - 01/2007
2Radiation-Sensitizing AgentsIBA
05/2011 - 02/2008
2Histone Deacetylase InhibitorsIBA
10/2010 - 06/2009
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2010 - 03/2006
2VorinostatFDA Link
10/2009 - 06/2009
2KSR-1 protein kinaseIBA
08/2008 - 08/2002
2SteroidsIBA
08/2008 - 09/2003
2AgarIBA
05/2005 - 09/2003
2Serine (L-Serine)FDA Link
02/2003 - 08/2002
1Immunoglobulin G (IgG)IBA
02/2024
1Pentamidine (NebuPent)FDA LinkGeneric
01/2023
1ClathrinIBA
01/2023
1AlbuminsIBA
01/2023
1GlycosphingolipidsIBA
01/2023
1neonatal Fc receptorIBA
01/2023
1Galectin 3 (LGALS3)IBA
01/2023
1Cell-Free Nucleic AcidsIBA
01/2023
1Liposomes (Liposome)IBA
10/2022
1Semaphorin-3AIBA
01/2021
1Fluorescent Dyes (Fluorescent Probes)IBA
11/2020
1prexasertibIBA
01/2020
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1Conditioned Culture MediaIBA
01/2019
1GTP Phosphohydrolases (GTPases)IBA
01/2019
1Death Domain ReceptorsIBA
01/2019
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2019
1CaspasesIBA
01/2019
1tropomyosin kinaseIBA
01/2019
1Dynamin IIIBA
01/2019
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1Transferrin (beta 2 Transferrin)IBA
01/2019
1TNF-Related Apoptosis-Inducing LigandIBA
01/2019
1Estradiol (Delestrogen)FDA LinkGeneric
01/2019
1Dynamins (Dynamin)IBA
01/2019
1Nucleoside-Diphosphate KinaseIBA
02/2018
1phosphohistidineIBA
02/2018
1Succinic Acid (Succinate)IBA
02/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Phosphates (Orthophosphate)IBA
01/2018

Therapy/Procedure

31Therapeutics
10/2022 - 02/2003
6Lasers (Laser)
11/2023 - 11/2002
6Drug Therapy (Chemotherapy)
01/2023 - 10/2009
5Radiotherapy
01/2023 - 08/2008
2Secondary Prevention
01/2023 - 05/2020
2Craniotomy
11/2016 - 06/2013
2Injections
07/2014 - 11/2013
2Chemoprevention
05/2011 - 12/2006
1Combined Modality Therapy
01/2019
1Immunotherapy
01/2019